These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15451520)

  • 1. In vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheres.
    Jiang HL; Park IK; Shin NR; Kang SG; Yoo HS; Kim SI; Suh SB; Akaike T; Cho CS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):471-6. PubMed ID: 15451520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.
    Kang ML; Jiang HL; Kang SG; Guo DD; Lee DY; Cho CS; Yoo HS
    Vaccine; 2007 Jun; 25(23):4602-10. PubMed ID: 17485148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in pigs.
    Kang ML; Kang SG; Jiang HL; Guo DD; Lee DY; Rayamahji N; Seo YS; Cho CS; Yoo HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1179-85. PubMed ID: 18600065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro.
    Jiang HL; Park IK; Shin NR; Yoo HS; Akaike T; Cho CS
    Arch Pharm Res; 2004 Mar; 27(3):346-50. PubMed ID: 15089042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.
    Kang ML; Kang SG; Jiang HL; Shin SW; Lee DY; Ahn JM; Rayamahji N; Park IK; Shin SJ; Cho CS; Yoo HS
    Eur J Pharm Biopharm; 2006 Jun; 63(2):215-20. PubMed ID: 16531027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
    Jiang HL; Kang ML; Quan JS; Kang SG; Akaike T; Yoo HS; Cho CS
    Biomaterials; 2008 Apr; 29(12):1931-9. PubMed ID: 18221992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
    Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
    Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive and pH-sensitive thiolated Eudragit microspheres for oral delivery of Pasteurella multocida antigens containing dermonecrotoxin.
    Islam MA; Jiang HL; Quan JS; Arote RB; Kang ML; Yoo HS; Yun CH; Choi YJ; Cho CS
    J Nanosci Nanotechnol; 2011 May; 11(5):4174-81. PubMed ID: 21780423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression.
    Akbuğa J; Ozbaş-Turan S; Erdoğan N
    Eur J Pharm Biopharm; 2004 Nov; 58(3):501-7. PubMed ID: 15451524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli.
    Kong M; Chen XG; Liu CS; Liu CG; Meng XH; Yu le J
    Colloids Surf B Biointerfaces; 2008 Sep; 65(2):197-202. PubMed ID: 18508247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
    Ventura CA; Tommasini S; Crupi E; Giannone I; Cardile V; Musumeci T; Puglisi G
    Eur J Pharm Biopharm; 2008 Feb; 68(2):235-44. PubMed ID: 17614266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
    Tian J; Yu J; Sun X
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):220-9. PubMed ID: 18722672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
    Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
    Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Field trial for control of atrophic rhinitis by vaccination with Bordetella bronchiseptica].
    Keller H; Loretz H
    Schweiz Arch Tierheilkd; 1980 Oct; 122(10):541-51. PubMed ID: 7466336
    [No Abstract]   [Full Text] [Related]  

  • 17. Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy.
    Saha TK; Ichikawa H; Fukumori Y
    Carbohydr Res; 2006 Dec; 341(17):2835-41. PubMed ID: 17045253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
    Zhai RL; Xu HY; Wang YL; Qin ZM; Jiang SJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):692-6. PubMed ID: 17944374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunity induced by H.pylori vaccine with chitosan as adjuvant].
    Gong YF; Xie Y; Zhou NJ; Chen J; Zhou XJ; Lu NH; Wang CW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):595-9. PubMed ID: 17618575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.